We are live on ! Find out more
CGTX icon

Cognition Therapeutics

78 hedge funds and large institutions have $28.9M invested in Cognition Therapeutics in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

15% more capital inflows, than outflows

Capital inflows: $4.82M | Capital outflows: $4.19M

13% more funds holding

Funds holding: 69 → 78 (+9)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

4.66% less ownership

Funds ownership: 28.93% → 24.27% (-4.7%)

Holders
78
Holders Change
+9
Holders Change %
+13.04%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
17
Increased
16
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CGTX Hedge Fund Activity: Q4 2025 in Review

78 of the 8,319 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q4 2025, worth a combined $28.9M — up 0.71% from $28.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CGTX positions and 8 closed out — a net gain of 9 holders — while 16 added to existing stakes and 16 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.03M. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.62M sold.

  • 78 institutional investors held Cognition Therapeutics (CGTX) as of Q4 2025, up from 69 in Q3 2025.
  • Funds reported $28.9M of Cognition Therapeutics stock for Q4 2025, up 0.71% quarter-over-quarter.
  • 17 funds opened new Cognition Therapeutics positions in Q4 2025 and 8 closed out, a net change of +9 holders.
  • The largest Cognition Therapeutics buyer in Q4 2025 was Vanguard Group, an estimated $1.03M added.
  • The largest Cognition Therapeutics seller in Q4 2025 was Tang Capital Management, an estimated $1.62M sold.

Based on aggregated 13F filings for Q4 2025.